151 related articles for article (PubMed ID: 2599072)
1. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
Ratunova TM; Bauman VR; Kalvin'sh IIa
Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical characteristics of the anti-ischemic action of the new structural analog of gamma-butyrobetaine 3-(2,2,2,-trimethylhydrazine)propionate].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1987; 50(2):100-4. PubMed ID: 3582624
[TBL] [Abstract][Full Text] [Related]
3. [Cardioprotective effect of carnitine and its synthetic analog 3-(2,2,2-trimethylhydrazinium) propionate in rats with experimental myocardial infarction].
Ianson TM; Bauman VR; Grom NP; Kienkas IA; Kalvin'sh IIa
Vopr Med Khim; 1988; 34(4):122-5. PubMed ID: 3195125
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a new structural analog of gamma-butyrobetaine-- 3-(2,2,2-trimethylhydrazine)propionate (THP) on carnitine level, carnitine-dependent fatty acid oxidation and various indices of energy metabolism in the myocardium].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1986; 32(4):72-6. PubMed ID: 3765501
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts.
Kirimoto T; Nobori K; Asaka N; Muranaka Y; Tajima K; Miyake H
Arch Int Pharmacodyn Ther; 1996; 331(2):163-78. PubMed ID: 8937627
[TBL] [Abstract][Full Text] [Related]
6. [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].
Simkhovich BZ; Meĭrena DV; Shutenko ZhV; Khagi KhB; Briede IaL
Vopr Med Khim; 1988; 34(5):30-4. PubMed ID: 3218133
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity.
Dambrova M; Makrecka-Kuka M; Vilskersts R; Makarova E; Kuka J; Liepinsh E
Pharmacol Res; 2016 Nov; 113(Pt B):771-780. PubMed ID: 26850121
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of carnitine-dependent metabolism of fatty acids in the rat myocardium using 3-(2,2,2-trimethylhydrazinium) propionate].
Shutenko ZhV; Simkhovich BZ; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1989; 35(2):59-64. PubMed ID: 2741413
[TBL] [Abstract][Full Text] [Related]
9. [The effect of a structural analog of gamma-butyrobetaine, mildronate, [3-2,2,2-trimethylhydrazine)propionate] on dynamic carnitine-dependent metabolism].
Shutenko ZhV; Priedena IA; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(3):24-6. PubMed ID: 1949676
[TBL] [Abstract][Full Text] [Related]
10. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
Liepinsh E; Vilskersts R; Zvejniece L; Svalbe B; Skapare E; Kuka J; Cirule H; Grinberga S; Kalvinsh I; Dambrova M
Br J Pharmacol; 2009 Aug; 157(8):1549-56. PubMed ID: 19594753
[TBL] [Abstract][Full Text] [Related]
12. Mildronate: cardioprotective action through carnitine-lowering effect.
Dambrova M; Liepinsh E; Kalvinsh I
Trends Cardiovasc Med; 2002 Aug; 12(6):275-9. PubMed ID: 12242052
[TBL] [Abstract][Full Text] [Related]
13. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties.
Simkhovich BZ; Shutenko ZV; Meirena DV; Khagi KB; Mezapuķe RJ; Molodchina TN; Kalviņs IJ; Lukevics E
Biochem Pharmacol; 1988 Jan; 37(2):195-202. PubMed ID: 3342076
[TBL] [Abstract][Full Text] [Related]
14. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level].
Simkhovich BZ; Vitolinia RO; Stivrinia MI; Shutenko ZhV; Meĭrena DV
Kardiologiia; 1987 Jul; 27(7):85-8. PubMed ID: 3656926
[TBL] [Abstract][Full Text] [Related]
16. L-carnitine for the treatment of acute myocardial infarction.
Dinicolantonio JJ; Niazi AK; McCarty MF; Lavie CJ; Liberopoulos E; O'Keefe JH
Rev Cardiovasc Med; 2014; 15(1):52-62. PubMed ID: 24762466
[TBL] [Abstract][Full Text] [Related]
17. [L-propionylcarnitine taurine amide induces the metabolic recovery of the isolated postischemic rat heart].
Lazzarino G; Corsico N; Tavazzi B; di Pierro D; Arrigoni-Martelli E; Giardina B
Cardiologia; 1992 Oct; 37(10):715-7. PubMed ID: 1296879
[TBL] [Abstract][Full Text] [Related]
18. The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
Kuka J; Vilskersts R; Cirule H; Makrecka M; Pugovics O; Kalvinsh I; Dambrova M; Liepinsh E
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):215-22. PubMed ID: 21903968
[TBL] [Abstract][Full Text] [Related]
19. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney.
Kuwajima M; Harashima H; Hayashi M; Ise S; Sei M; Lu Km; Kiwada H; Sugiyama Y; Shima K
J Pharmacol Exp Ther; 1999 Apr; 289(1):93-102. PubMed ID: 10086992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
